Product Information
CICLOPIROX 0.77% TOPICAL SUSP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.5953 per ML under NDC 45802040049. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Ciclopirox Olamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.7 mg/100mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802040049
Classification
Generic
Dosage Form
SUSPENSION
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
CICLOPIROX OLAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA077676On Market Since
12/29/2006
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 0.77% TOPICAL SUSP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5953 per ML |
|---|---|
| All-time high | $1.6970 (Sep 14, 2016) |
| All-time low | $0.3262 (Apr 22, 2015) |
| 52-week high | $0.7797 |
| 52-week low | $0.5857 |
| Median price | $0.8371 |
| Average price | $0.8329 |
| Largest weekly change | +130.8% (May 18, 2016) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CICLOPIROX 0.77% TOPICAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 0.77% TOPICAL SUSP, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.5953 per ML (NDC 45802040049), effective Jun 24, 2026.
How has the price of CICLOPIROX 0.77% TOPICAL SUSP changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 0.77% TOPICAL SUSP has risen 26.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 0.77% TOPICAL SUSP?
Since Nov 28, 2013, the NADAC for CICLOPIROX 0.77% TOPICAL SUSP has ranged from a low of $0.3262 (Apr 22, 2015) to a high of $1.6970 (Sep 14, 2016), with a median of $0.8371 per ML.
Are there cheaper alternatives to CICLOPIROX 0.77% TOPICAL SUSP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CICLOPIROX 0.77% TOPICAL SUSP, is $0.5852 per ML — about 2% below CICLOPIROX 0.77% TOPICAL SUSP.
Who manufactures CICLOPIROX 0.77% TOPICAL SUSP?
CICLOPIROX 0.77% TOPICAL SUSP (NDC 45802040049) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification